FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 307:709-713 September 16, 1982 Number 12 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

A histochemical stain for bone aluminum allowed us to determine the prevalence and staining characteristics of aluminum in renal osteodystrophy. The staining method correlated well with the results of atomic-absorption studies in 96 samples (r = 0.81; P less than 0.001). We examined 315 bone-biopsy samples. No aluminum was seen in controls or patients with nonrenal bone disease. In renal osteodystrophy, the mean level of stainable aluminum was significantly higher in osteomalacic lesions (1.12 +/- 0.09 mm per square millimeter of tissue area) than in mild, mixed, of fibrotic lesions (0.43 +/- 0.06, 0.34 +/- 0.11, and 0.10 +/- 0.03 mm per square millimeter, respectively; P less than 0.001). Seventy per cent of osteomalacic samples had heavy aluminum staining. The bone-apposition rate, measured by double tetracycline labels, was low in 89 per cent of the samples with high levels of aluminum. The mean level of stainable bone aluminum in patients who had a clinical response to calcitriol was significantly lower than in those who did not respond (0.13 +/- 0.4 vs. 1.06 +/- 0.9 mm per square millimeter; P less than 0.01). We conclude that aluminum deposition is associated with impaired bone formation or mineralization and with a poor response to calcitriol therapy.

This article has been cited by other articles:

• Brandenburg, V. M., Floege, J. (2008). Adynamic bone disease--bone and beyond. NDT Plus 1: 135-147 [Full Text]  
• Yokel, R. A., Meurer, K. A., Hong, C. B., Dickey, K. M., Skinner, T. L., Fredenburg, A. M. (1997). Short-Term Oral 3-Hydroxypyridin-4-one Dosing Increases Aluminum Excretion and Partially Reverses Aluminum-Induced Toxicity in the Rabbit Independent of Chelator Lipophilicity. Drug Metab. Dispos. 25: 182-190 [Abstract] [Full Text]  
• Lote, C., Wood, J., Thewles, A., Freeman, M. (1995). Renal filtration and excretion of aluminium in the rat: dose-response relationships and effects of aluminium speciation. Hum Exp Toxicol 14: 494-499 [Abstract]  
• Gómez, M., Domingo, J.L., del Castillo, D., Llobet, J.M., Corbella, J. (1994). Comparative Aluminium Mobilizing Actions of Several Chelators in Aluminium-Loaded Uraemic Rats. Hum Exp Toxicol 13: 135-139 [Abstract]  
• ASCN/A.S.P.E.N. WORKING GROUP ON STANDARDS FOR ALU, (1991). Parenteral Drug Products Containing Aluminum as an Ingredient or a Contaminant: Response to Food and Drug Administration Notice of Intent and Request for Information. JPEN J Parenter Enteral Nutr 15: 194-198 [Abstract]  
• Brem, A. S., DiMario, C., Levy, D. L. (1989). Perceived Aluminum-Related Disease in a Dialysis Population: A Report From the End-Stage Renal Disease Network 28. Arch Intern Med 149: 2541-2544 [Abstract]  
• Yokel, R. A. (1988). Aluminum and Alzheimer's Disease: Should We Worry?. Journal of Pharmacy Practice 1: 118-127  
• Klein, G. L., Sedman, A. B., Heyman, M. B., Marathe, G., Battifora, H. A., Worrall, J. L., Horst, R. L., Brewer, G. J., Miller, N. L., Alfrey, A. C. (1987). Hepatic Abnormalities Associated with Aluminum Loading in Piglets. JPEN J Parenter Enteral Nutr 11: 293-297 [Abstract]  
• Reasner, C., Mundy, G. R. (1986). Hypercalcemia in the Critically Ill Patient. J Intensive Care Med 1: 319-328 [Abstract]  
• Koo, W. W.K., Kaplan, L. A., Horn, J., Tsang, R. C., Steichen, J. J. (1986). Aluminum in Parenteral Nutrition Solution--Sources and Possible Alternatives. JPEN J Parenter Enteral Nutr 10: 591-595 [Abstract]  
• Marein, C., Misny, P., Paysinger, J., O'Neill, M., Sharp, J., Srp, F., Dale Gulledge, A., Holpit, L., Matarese, L., Steiger, E. (1986). Invited Review: Home Parenteral Nutrition. Nutr Clin Pract 1: 179-192  
• MILLINER, D. S., NEBEKER, H. G., OTT, S. M., ANDRESS, D. L., SHERRARD, D. J., ALFREY, A. C., SLATOPOLSKY, E. A., COBURN, J. W. (1984). Use of the Deferoxamine Infusion Test in the Diagnosis of Aluminum-Related Osteodystrophy. ANN INTERN MED 101: 775-780 [Abstract]  
• Skalsky, H. L., Carchman, R. A. (1983). Aluminum Homeostasis in Man. International Journal of Toxicology 2: 405-423 [Abstract]  
• OTT, S. M., MALONEY, N. A., KLEIN, G. L., ALFREY, A. C., AMENT, M. E., COBURN, J. W., SHERRARD, D. J. (1983). Aluminum Is Associated with Low Bone Formation in Patients Receiving Chronic Parenteral Nutrition. ANN INTERN MED 98: 910-914 [Abstract]  
• Voigts, A. L., Felsenfeld, A. J., Llach, F. (1983). The Effects of Calciferol and Its Metabolites on Patients With Chronic Renal Failure: II. Calcitriol, 1{alpha}-Hydroxyvitamin D3, and 24,25-Dihydroxyvitamin D3. Arch Intern Med 143: 1205-1211 [Abstract]